MicroRNA, Insulin Resistance, and Metabolic Disorders 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 244
Special Issue Editor
2. Channelopathy Research Center (CRC), Dongguk University School of Medicine, Ilsan 10326, Republic of Korea
Interests: mechanotransduction; cytoskeleton remodeling; proliferation; differentiation; myogenesis; sarcopenia; insulin resistance; diabetes; metabolism; glucose metabolism; lipid metabolism; metabolic diseases; energy metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Insulin resistance, characterized as inadequate insulin signal transduction within cells, is a major global health issue linked to various diseases, including type 2 diabetes, dyslipidemia, hypertension, and atherosclerosis. Over the last few decades, microRNAs (miRNAs) are becoming a hot topic in molecular and cellular biology as "key modulators" of physiological and pathophysiological processes. They can orchestrate cell-to-cell communication and mediate cellular processes in numerous ways by controlling gene expression at the transcriptional, post-transcriptional, and translational levels. Despite growing evidence that miRNAs play a significant prognostic and therapeutic role in insulin resistance and metabolic diseases, the precise mechanisms by which miRNAs lead to insulin resistance and metabolic disorders are unclear.
This Special Issue will discover the novel function and mechanism of miRNAs in the pathogenesis of insulin resistance and metabolic disorders in various tissues and organs. Additionally, this issue will discuss recent advances in the development and potential application of miRNAs as novel biomarkers and therapeutic targets for metabolic diseases. We encourage contributions of original research and review articles on all aspects of miRNAs associated with insulin resistance and metabolic disorders.
More published papers could be found in the closed Special Issue: MicroRNA, Insulin Resistance, and Metabolic Disorders.
Prof. Dr. Wan Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microRNA
- insulin resistance
- metabolic diseases
- insulin signaling
- diabetes
- obesity
